Authors: Santagostino, E Morfini, M Rocino, A Baudo, F Scaraggi, FA Gringeri, A

Citation: E. Santagostino et al., Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors, THROMB HAEM, 86(4), 2001, pp. 954-958

Authors: De Mitrio, V Marino, R Scaraggi, FA Di Bari, L Giannoccaro, F Petronelli, M Ranieri, P Tannoia, N Schiraldi, O

Citation: V. De Mitrio et al., Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation, BL COAG FIB, 10(7), 1999, pp. 409-416

Authors: Scaraggi, FA De Mitrio, V Marino, R Speciale, V Di Bari, L Petronelli, M Schiraldi, O

Citation: Fa. Scaraggi et al., Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections, BL COAG FIB, 10(1), 1999, pp. 33-38

Authors: De Mitrio, V De Pergola, G Vettor, R Marino, R Sciaraffia, M Pagano, C Scaraggi, FA Di Lorenzo, L Giorgino, R

Citation: V. De Mitrio et al., Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women, METABOLISM, 48(8), 1999, pp. 960-964